Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Diabetes

Free Subscription Articles published in JAMA Retrieve available abstracts of 97 articles: HTML format

Single Articles

April 2026
1. ANDERER S
   FDA Approves Weekly Basal Insulin for Adults With Type 2 Diabetes.
   JAMA. 2026 Apr 17. doi: 10.1001/jama.2026.2111.
   PubMed    
   
   
   
2. ABBASI J
   PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC.
   JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2399.
   PubMed    
   
   
   
3. ANDERER S
   Triple Agonist Reduces Hemoglobin A1C and Weight in Patients With Type 2 Diabetes.
   JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2107.
   PubMed    
   
   
   March 2026
4. 
   Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Research Summary.
   JAMA. 2026 Mar 28:e263429. doi: 10.1001/jama.2026.3429.
   PubMed    
   
   
   
5. MARSTON NA, Bohula EA, Bhatia AK, De Ferrari GM, et al
   Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial.
   JAMA. 2026 Mar 28:e263277. doi: 10.1001/jama.2026.3277.
   PubMed     Abstract available
   
   
   February 2026
6. ZAVALETA-MONESTEL E, Arguedas-Chacon S
   AI-Driven Diabetes Prevention Program.
   JAMA. 2026 Feb 23. doi: 10.1001/jama.2025.26491.
   PubMed    
   
   
   
7. LALANI B, Mathioudakis N
   AI-Driven Diabetes Prevention Program-Reply.
   JAMA. 2026 Feb 23. doi: 10.1001/jama.2025.26494.
   PubMed    
   
   
   
8. ANDERER S
   Maternal Diabetes Associated With Increased Risk of Epilepsy in Children.
   JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26396.
   PubMed    
   
   
   
9. WALTER K
   What Is Type 1 Diabetes?
   JAMA. 2026 Feb 16. doi: 10.1001/jama.2026.0561.
   PubMed    
   
   
   
10. JACOBSEN LM, Schatz DA
    Type 1 Diabetes: A Review.
    JAMA. 2026 Feb 16. doi: 10.1001/jama.2026.0048.
    PubMed     Abstract available
    
    
    January 2026
11. ANDERER S
    High-Dose Flu Vaccine Demonstrates Benefits in Older Adults With Diabetes.
    JAMA. 2026 Jan 30. doi: 10.1001/jama.2025.26366.
    PubMed    
    
    
    
12. ANDERER S
    Higher Food Preservative Intake Linked With Type 2 Diabetes.
    JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.23033.
    PubMed    
    
    
    
13. NEUEN BL, Fletcher RA, Anker SD, Bhatt DL, et al
    SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
    JAMA. 2026;335:233-244.
    PubMed     Abstract available
    
    
    
14. VOELKER R
    What Is Type 2 Diabetes?
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.23179.
    PubMed    
    
    
    
15. TILG H, Petta S, Stefan N, Targher G, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review.
    JAMA. 2026;335:163-174.
    PubMed     Abstract available
    
    
    
16. ANDERER S
    Some Diabetes Drugs May Slow Frailty Progression in Older Adults.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23007.
    PubMed    
    
    
    December 2025
17. ANDERER S
    WHO Releases First Global Guidelines for Diabetes Management in Pregnancy.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20013.
    PubMed    
    
    
    November 2025
18. MAYA J, Pant D, Fu Y, James K, et al
    Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
    JAMA. 2025 Nov 24:e2520951. doi: 10.1001/jama.2025.20951.
    PubMed     Abstract available
    
    
    
19. MAUERMANN ML, Staff NP
    Peripheral Neuropathy: A Review.
    JAMA. 2025 Nov 17. doi: 10.1001/jama.2025.19400.
    PubMed     Abstract available
    
    
    
20. PANT S
    FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19724.
    PubMed    
    
    
    
21. STAPLIN N, Roddick AJ, Neuen BL, Anker SD, et al
    Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis.
    JAMA. 2025 Nov 7:e2520835. doi: 10.1001/jama.2025.20835.
    PubMed     Abstract available
    
    
    October 2025
22. PERREAULT L
    Artificial Intelligence and Diabetes Prevention.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.20099.
    PubMed    
    
    
    
23. MATHIOUDAKIS N, Lalani B, Abusamaan MS, Alderfer M, et al
    An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial.
    JAMA. 2025 Oct 27:e2519563. doi: 10.1001/jama.2025.19563.
    PubMed     Abstract available
    
    
    
24. DONOVAN LE, Lemieux P, Dunlop AD, Yamamoto JM, et al
    Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial.
    JAMA. 2025 Oct 24:e2519578. doi: 10.1001/jama.2025.19578.
    PubMed     Abstract available
    
    
    
25. KRUGER N, Schneeweiss S, Fuse K, Matseyko S, et al
    Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction.
    JAMA. 2025;334:1255-1266.
    PubMed     Abstract available
    
    
    September 2025
26. VAN DER WEL AWT, Frank CMC, Bout-Rebel R, Duijnhoven RG, et al
    Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
    JAMA. 2025 Sep 8:e2513668. doi: 10.1001/jama.2025.13668.
    PubMed     Abstract available
    
    
    
27. SCHNEIDER L
    1 in 4 US Adults With Diabetes Used Injectable GLP-1 Drugs Last Year.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.13363.
    PubMed    
    
    
    July 2025
28. ANDERER S
    Once-Weekly Basal Insulin Matches Daily Option in Type 2 Diabetes Trial.
    JAMA. 2025 Jul 18. doi: 10.1001/jama.2025.10332.
    PubMed    
    
    
    June 2025
29. XU F
    Prevalence and Control of Diabetes Among US Adults.
    JAMA. 2025 Jun 30. doi: 10.1001/jama.2025.6305.
    PubMed    
    
    
    
30. INOUE K, Liu M, Wadhera RK
    Prevalence and Control of Diabetes Among US Adults-Reply.
    JAMA. 2025 Jun 30. doi: 10.1001/jama.2025.6308.
    PubMed    
    
    
    
31. ANDERER S
    Measuring Skin Water Loss Could Predict Diabetic Foot Ulcer Recurrence.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.9645.
    PubMed    
    
    
    
32. KALYANI RR, Neumiller JJ, Maruthur NM, Wexler DJ, et al
    Diagnosis and Treatment of Type 2 Diabetes in Adults: A Review.
    JAMA. 2025 Jun 23. doi: 10.1001/jama.2025.5956.
    PubMed     Abstract available
    
    
    
33. WANG Q, Zhang Z, Niu W
    Age and Sex Differences in Treatment Efficacy for Type 2 Diabetes.
    JAMA. 2025 Jun 4. doi: 10.1001/jama.2025.4413.
    PubMed    
    
    
    
34. HANLON P, Phillippo D, McAllister D
    Age and Sex Differences in Treatment Efficacy for Type 2 Diabetes-Reply.
    JAMA. 2025 Jun 4. doi: 10.1001/jama.2025.4416.
    PubMed    
    
    
    May 2025
35. RADEMAKER D, DeVries JH, van Rijn BB
    Oral Glucose-Lowering Agents and Large-for-Gestational-Age Infants in Gestational Diabetes-Reply.
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.2943.
    PubMed    
    
    
    
36. SU C
    Oral Glucose-Lowering Agents and Large-for-Gestational-Age Infants in Gestational Diabetes.
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.2940.
    PubMed    
    
    
    
37. ANDERER S
    Tirzepatide Outperforms Dulaglutide for Type 2 Diabetes Control.
    JAMA. 2025 May 2. doi: 10.1001/jama.2025.5645.
    PubMed    
    
    
    April 2025
38. ANDERER S
    Automated Insulin Delivery May Benefit Patients With Type 2 Diabetes.
    JAMA. 2025 Apr 18. doi: 10.1001/jama.2025.4670.
    PubMed    
    
    
    
39. PERLIS R, Schweitzer K
    Diabetic Retinopathy Is Massively Underscreened-an AI System Could Help.
    JAMA. 2025 Apr 18. doi: 10.1001/jama.2025.2778.
    PubMed    
    
    
    March 2025
40. DIELEMAN JL, Beauchamp M, Crosby SW, DeJarnatt D, et al
    Tracking US Health Care Spending by Health Condition and County.
    JAMA. 2025;333:1051-1061.
    PubMed     Abstract available
    
    
    
41. ANDERER S
    FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.1352.
    PubMed    
    
    
    
42. ANDERER S
    Certain Diabetes Medications May Help Lower COPD Exacerbation Risk.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.1357.
    PubMed    
    
    
    February 2025
43. INOUE K, Liu M, Aggarwal R, Marinacci LX, et al
    Prevalence and Control of Diabetes Among US Adults, 2013 to 2023.
    JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.28513.
    PubMed    
    
    
    
44. BOCK A
    Studies Find Low Risk of Thyroid Cancer With GLP-1 Drugs for Diabetes.
    JAMA. 2025 Feb 14. doi: 10.1001/jama.2025.0248.
    PubMed    
    
    
    
45. ANDERER S
    Systematic Review Examines GLP-1 Drugs' Effectiveness and Safety in Patients Without Diabetes.
    JAMA. 2025 Feb 7. doi: 10.1001/jama.2025.0242.
    PubMed    
    
    
    
46. HANLON P, Butterly E, Wei L, Wightman H, et al
    Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
    JAMA. 2025 Feb 3:e2427402. doi: 10.1001/jama.2024.27402.
    PubMed     Abstract available
    
    
    January 2025
47. ANDERER S
    Sweetened Beverages Linked to Millions of Global Diabetes and Heart Disease Cases.
    JAMA. 2025 Jan 31. doi: 10.1001/jama.2024.28816.
    PubMed    
    
    
    
48. NICHOLLS SJ, Ni W, Rhodes GM, Nissen SE, et al
    Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.
    JAMA. 2025;333:222-231.
    PubMed     Abstract available
    
    
    
49. POWE CE
    For Gestational Diabetes Pharmacotherapy, Insulin Reigns Supreme.
    JAMA. 2025 Jan 6. doi: 10.1001/jama.2024.27148.
    PubMed    
    
    
    
50. RADEMAKER D, de Wit L, Duijnhoven RG, Voormolen DN, et al
    Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2025 Jan 6. doi: 10.1001/jama.2024.23410.
    PubMed     Abstract available
    
    
    December 2024
51. LIMONTE CP, Pilla SJ, de Boer IH
    Diabetes and Chronic Kidney Disease.
    JAMA. 2024 Dec 26. doi: 10.1001/jama.2024.24671.
    PubMed    
    
    
    November 2024
52. 
    The Statistics of Diabetes.
    JAMA. 2024 Nov 27. doi: 10.1001/jama.2023.18494.
    PubMed    
    
    
    
53. ANDERER S
    Low-Carbohydrate Diet May Boost beta-Cell Function in Mild Type 2 Diabetes.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.23622.
    PubMed    
    
    
    
54. ANDERER S
    Creatine Likely a Marker, Not a Cause, of Insulin Resistance in Type 2 Diabetes.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22566.
    PubMed    
    
    
    October 2024
55. LI P, Li Z, Staton E, Umpierrez GE, et al
    GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes.
    JAMA. 2024 Oct 23:e2418581. doi: 10.1001/jama.2024.18581.
    PubMed    
    
    
    
56. ANDERER S
    Weekly Insulin May Be as Effective as Once Daily for Type 2 Diabetes.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20116.
    PubMed    
    
    
    September 2024
57. DURKIN C
    Highs and Lows.
    JAMA. 2024;332:965-966.
    PubMed    
    
    
    
58. ANDERER S
    Risk Factors for Immune Checkpoint Inhibitor-Induced Diabetes Identified.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19134.
    PubMed    
    
    
    
59. ANDERER S
    FDA Approves First Automated Insulin Device for Type 2 Diabetes.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19129.
    PubMed    
    
    
    
60. MOJSOV S
    Chemistry Matters-From a Putative Peptide to Effective Treatments for Diabetes and Obesity: 2024 Lasker-DeBakey Clinical Medical Research Award.
    JAMA. 2024 Sep 19. doi: 10.1001/jama.2024.17571.
    PubMed    
    
    
    August 2024
61. HEGLAND TA, Fang Z, Bucher K
    GLP-1 Medication Use for Type 2 Diabetes Has Soared.
    JAMA. 2024 Aug 30. doi: 10.1001/jama.2024.18219.
    PubMed    
    
    
    
62. ANDERER S
    Study of Historic Famine Strengthens Link Between Prenatal Malnutrition and Type 2 Diabetes.
    JAMA. 2024 Aug 30. doi: 10.1001/jama.2024.15891.
    PubMed    
    
    
    
63. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
    JAMA. 2024 Aug 14:e2411463. doi: 10.1001/jama.2024.11463.
    PubMed     Abstract available
    
    
    
64. CURFMAN G
    Chelation Therapy Following Myocardial Infarction.
    JAMA. 2024 Aug 14. doi: 10.1001/jama.2024.13549.
    PubMed    
    
    
    July 2024
65. ABBASI J
    New Data on GLP-1s, Diabetic Retinopathy, and CGMs-Highlights From the ADA's Scientific Sessions.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.11510.
    PubMed    
    
    
    
66. BOCK A
    Study: Semaglutide Lowered Chronic Kidney Disease-Related Risks.
    JAMA. 2024;332:188.
    PubMed    
    
    
    
67. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    PubMed    
    
    
    
68. HARRIS E
    Fasting, Meal Substitute Improved Blood Sugar More Than Diabetes Drugs.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12233.
    PubMed    
    
    
    
69. HARRIS E
    Guidelines May Fall Short as More Older Adults Live With Type 1 Diabetes.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12235.
    PubMed    
    
    
    
70. MILDER DA, Milder TY, Kam P
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:170-171.
    PubMed    
    
    
    
71. HOBAI IA
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:171-172.
    PubMed    
    
    
    
72. LEVI M
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:171.
    PubMed    
    
    
    
73. HARRIS E
    Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable.
    JAMA. 2024;332:8.
    PubMed    
    
    
    June 2024
74. LEE JM, Sharifi M, Oshman L, Griauzde DH, et al
    Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023.
    JAMA. 2024;331:2041-2043.
    PubMed    
    
    
    
75. BEHESHTIROUY S, Shayanfar A
    A Review of Thyroid Cancer.
    JAMA. 2024;331:1862-1863.
    PubMed    
    
    
    
76. BOUCAI L, Zafereo M, Cabanillas ME
    A Review of Thyroid Cancer-Reply.
    JAMA. 2024;331:1863-1864.
    PubMed    
    
    
    
77. COURCOULAS AP, Patti ME, Kirwan JP
    Medical Management vs Bariatric Surgery in Type 2 Diabetes-Reply.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.8852.
    PubMed    
    
    
    
78. FUJIEDA T
    Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.8849.
    PubMed    
    
    
    May 2024
79. DIXIT AA, Bateman BT, Hawn MT, Odden MC, et al
    Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;331:1672-1673.
    PubMed    
    
    
    
80. MCKENNA M
    Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
    JAMA. 2024;331:1433-1436.
    PubMed    
    
    
    April 2024
81. MACHIAVELLO ROMAN FJ, Azar MM, Trubin PA
    A Patient With Type 1 Diabetes and Acute Rhinosinusitis.
    JAMA. 2024 Apr 17. doi: 10.1001/jama.2024.0642.
    PubMed    
    
    
    
82. YOUNOSSI ZM
    Predicting Liver-Related Outcomes in Steatotic Liver Disease.
    JAMA. 2024;331:1274-1275.
    PubMed    
    
    
    
83. RUBIN R
    All of Us Program Illustrates What Less-Diverse Genomics Studies Might Be Missing.
    JAMA. 2024;331:1167-1168.
    PubMed    
    
    
    
84. HARRIS E
    Less Sleep Tied to Increased Risk of Diabetes Despite Healthy Diet.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4498.
    PubMed    
    
    
    
85. FANG M, Wang D, Selvin E
    Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.
    JAMA. 2024 Apr 4. doi: 10.1001/jama.2024.2103.
    PubMed    
    
    
    
86. POURKARIM F, Entezari-Maleki T
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1380.
    PubMed    
    
    
    
87. BOGGESS KA
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1383.
    PubMed    
    
    
    March 2024
88. MOZAFFARIAN D
    GLP-1 Agonists for Obesity-A New Recipe for Success?
    JAMA. 2024;331:1007-1008.
    PubMed    
    
    
    
89. THOMAS CC, Chopra K, Davis AM
    Management of Outpatients With Diabetes at High Risk of Hypoglycemia.
    JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.1137.
    PubMed    
    
    
    
90. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    PubMed    
    
    
    
91. RUDER K
    Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could Move the Needle.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
    PubMed    
    
    
    February 2024
92. WADDEN TA, Kushner RF, Chao AM
    Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    JAMA. 2024;331:643-645.
    PubMed    
    
    
    
93. COURCOULAS AP, Patti ME, Hu B, Arterburn DE, et al
    Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024;331:654-664.
    PubMed     Abstract available
    
    
    
94. MENG J, Tang H, Gao S
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:617-618.
    PubMed    
    
    
    
95. PARK Y, Kim NE, Lee SJ
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:618.
    PubMed    
    
    
    
96. DUNNE F, Newman C, Smyth A
    Early Metformin Treatment for Gestational Diabetes-Reply.
    JAMA. 2024;331:618-619.
    PubMed    
    
    
    
97. ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
    Delivery Device Patents on GLP-1 Receptor Agonists.
    JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum